Clinical Trial: SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680530) titled 'SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)' on June 16.

Brief Summary: The primary purpose of the clinical investigation is to verify the SpO2 accuracy of the Philips AlarX5 SpO2 sensor with Nellcor OxiMax SpO2 Board.

Study Start Date: May 28

Study Type: OBSERVATIONAL

Condition: Pulse Oximetry

Intervention: OTHER: Evaluation of Oxygen Sensors

The experimental Philips AlarX5 SpO2 sensor will be tested with Nellcor OxiMax pulse oximetry technology. The AlarX5 SpO2 sensor will be connected via an adapter cable to an IntelliVue X3 Patient Monitor integrated with a Nellcor OxiMax SpO2...